Revvity (RVTY) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Revvity (RVTY) Net Income towards Common Stockholders Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 8.89% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | -7.69% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | -6.41% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | 14.66% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 2.87% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 10.22% |
| 10 | Revvity | 12.81 Bn | 11.95 Bn | 387.66 Mn | -26.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -26.00% |
| Dec 28, 2025 | -55.86% |
| Sep 28, 2025 | -26.74% |
| Jun 29, 2025 | -27.49% |
| Mar 30, 2025 | 27.65% |
| Dec 29, 2024 | 0.91% |
| Sep 29, 2024 | -63.46% |
| Jun 30, 2024 | -43.49% |
| Mar 31, 2024 | -31.69% |
| Oct 1, 2023 | -753.10% |
| Apr 2, 2023 | 2,116.85% |
| Jan 1, 2023 | 757.42% |
| Oct 2, 2022 | 574.30% |
| Jul 3, 2022 | 589.73% |
| Apr 3, 2022 | -457.60% |
| Jan 2, 2022 | 489.80% |
| Oct 3, 2021 | 163.18% |
| Jul 4, 2021 | 216.24% |
| Apr 4, 2021 | 851.24% |
| Jan 3, 2021 | 69.89% |